Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Brain Natriuretic Peptide in Plasma as Predictor of All-Cause Mortality in a Large Danish Primary Health Care Population Suspected of Heart Failure

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Peripheral Neuropathy - time for better biomarkers?

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Perspectives on the Changing Landscape of Measuring Cardiovascular Risk Related to LDL

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Lipoprotein(a) Should Be Measured in All Individuals Suspected of Having Familial Hypercholesterolemia

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Cardiac natriuretic peptides

    Publikation: Bidrag til tidsskriftReviewForskningpeer review

  2. Distinct non-ischemic myocardial late gadolinium enhancement lesions in patients with type 2 diabetes

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Effect of insulin on natriuretic peptide gene expression in porcine heart

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. A compulsory pop-up form reduces the number of vitamin D requests from general practitioners by 25 percent

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

BACKGROUND: Measurement of B-type natriuretic peptide (BNP) in plasma may have its greatest potential in primary care, as general practitioners need to rapidly identify patients who warrant further medical review. The aim of the present study was to examine the prognostic information of BNP measurement on all-cause mortality in a large Danish primary care cohort.

METHODS: This study covered a cohort of Danish primary care patients (n = 61665) with a median follow-up period of 4.36 years (interquartile range, 2.29-6.62 years). BNP was measured in plasma using the ADVIA Centaur/ CentaurXP platform. The association of BNP with mortality was assessed with a hazard ratio for all-cause mortality from a multivariable Cox proportional hazards model.

RESULTS: Kaplan-Meier curves showed decreasing survival probability with increasing BNP (P < 0.001). Each doubling of BNP increased mortality by 32.3% (95% CI, 30.8-33.8) when adjusted for sex and age, and by 25.3% (95% CI, 23.8-26.8) when further adjusted for Charlson comorbidity index, hemoglobin, estimated glomerular filtration rate, glycohemoglobin, and thyroid-stimulating hormone. Also, in a subcohort (n = 10824) without biochemical signs of severe kidney failure, anemia, polycythemia, hypothyroidism or hyperthyroidism, or dysregulated diabetes, each doubling of BNP increased mortality by 28.6% (95% CI, 22.8-34.7).

CONCLUSIONS: Our results show that even in a primary care population, BNP measurements contain prognostic information regarding all-cause mortality.

OriginalsprogEngelsk
TidsskriftClinical Chemistry
Vol/bind64
Udgave nummer12
Sider (fra-til)1723-1731
ISSN0009-9147
DOI
StatusUdgivet - dec. 2018

ID: 55456902